ESH Video

3rd Translational Research Conference: Chronic Lymphocytic Leukaemia

3rd Translational Research Conference: Chronic Lymphocytic Leukaemia
March 08 - March 10, 2024 - Vienna, Austria - #ESHCLL2024
Chairs : Jennifer Brown, Paolo Ghia, Michael Hallek


3rd Translational Research Conference 
Chronic Lymphocytic Leukaemia

March 08-10, 2024

Vienna, Austria


Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek


The ESH 3rd Translational Research Conference: Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Chronic Lymphocytic Leukaemia (CLL) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of the disease.

The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy.


This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH).


Why the meeting will be valuable for participants?

– It fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide
– It provides opportunities for leading-edge education and international networking to basic and clinical scientists, including those still in-training
– A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.


Upon completion of this CME activity, participants should:
– Understand recent advances in elucidating the pathogenesis of CLL
– Describe recent data on therapeutic regimens for CLL
– Understand emerging data on mechanisms of resistance to targeted agents in CLL
– Understand the debate about how best to optimize CLL therapy in the future

– CLL disease progression
– Richters syndrome
– Biomarkers: where do we stand?
– Targeting the microenvironment in CLL
– What is the best time-limited therapy
– BTK inhibitors
– Small molecule resistance
– Next generation therapies
– The future: other targets

– Plenary Sessions
– Panel Discussions
– Poster Walks
– Meet the Expert Sessions



CLICK HERE to read the scientific programme.

Abstract submission



Abstracts guidelines:
– Your abstract has to be structured (eg Objectives, Methods, Results, Conclusions)
– Maximum number of words: 500
– Your abstract will be submitted to the peer review procedure.
The following file types may be uploaded: HTML document (*.htm), HTML document (*.html), JPEG image (*.jpg), GIF image (*.gif), or PNG image (*.png).


We accept “encore” abstract.

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.



Austria Trend Hotel Savoyen, Vienna, Austria (the conference venue)

In order to help you with your travel planning, a number of rooms have been blocked at a special rate for you.

For reservation, please send your request to


Austria Trend Hotel Savoyen
Rennweg 16
1030 Vienna

Corporate partners

With the support of*:

Major Conference Partner

Level 1 Conference Partner


Level 2 Conference Partner

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.



Educational Grants


The registration fee for the ESH 3rd Translational Research Conference on Chronic Lymphocytic Leukaemia is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.


ESH is pleased to offer BSH, DGHO and PTHiT Members a 20% discount on the conference registration fees.


This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.


Cancellation policy of registration fee :
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.